Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

Bile salt hydrolase activity is present in nonintestinal lactic acid bacteria at an intermediate level.

Ru X, Zhang CC, Yuan YH, Yue TL, Guo CF.

Appl Microbiol Biotechnol. 2019 Jan;103(2):893-902. doi: 10.1007/s00253-018-9492-5. Epub 2018 Nov 12.

PMID:
30421106
2.

Bile Salt Hydrolase and S-Layer Protein are the Key Factors Affecting the Hypocholesterolemic Activity of Lactobacillus casei-Fermented Milk in Hamsters.

Guo CF, Zhang S, Yuan YH, Li JY, Yue TL.

Mol Nutr Food Res. 2018 Dec;62(24):e1800728. doi: 10.1002/mnfr.201800728. Epub 2018 Nov 2.

PMID:
30346664
3.

Hamsters Are a Better Model System than Rats for Evaluating the Hypocholesterolemic Efficacy of Potential Probiotic Strains.

Guo CF, Yuan YH, Yue TL, Li JY.

Mol Nutr Food Res. 2018 Aug;62(16):e1800170. doi: 10.1002/mnfr.201800170. Epub 2018 Jul 26.

PMID:
29939474
4.

Bile acid patterns in commercially available oxgall powders used for the evaluation of the bile tolerance ability of potential probiotics.

Hu PL, Yuan YH, Yue TL, Guo CF.

PLoS One. 2018 Mar 1;13(3):e0192964. doi: 10.1371/journal.pone.0192964. eCollection 2018.

5.

A new method for the in vitro determination of the bile tolerance of potentially probiotic lactobacilli.

Hu PL, Yuan YH, Yue TL, Guo CF.

Appl Microbiol Biotechnol. 2018 Feb;102(4):1903-1910. doi: 10.1007/s00253-018-8742-x. Epub 2018 Jan 12.

PMID:
29330692
6.

[Differentiation and Identification of Alicyclobacillus Strains by Fourier Transform Near-Infrared Spectroscopy].

Wang RN, Yue TL, Yuan YH, Wang HX, Song YD, Wang J.

Guang Pu Xue Yu Guang Pu Fen Xi. 2015 Nov;35(11):3073-7. Chinese.

PMID:
26978911
7.

[Analysis of changes in minerals contents during cider fermentation process by inductively coupled plasma mass spectrometry].

Ye MQ, Yue TL, Gao ZP, Yuan YH, Nie G.

Guang Pu Xue Yu Guang Pu Fen Xi. 2015 Jan;35(1):229-33. Chinese.

PMID:
25993854
8.

[Study on mechanism of inactivated cider yeast adsorbing patulin by Fourier transform infrared spectroscopy].

Guo CX, Yue TL, Yuan YH, Wang ZL, Wang L, Cai R.

Guang Pu Xue Yu Guang Pu Fen Xi. 2013 Mar;33(3):672-6. Chinese.

PMID:
23705430
9.

Chronic inhibition of 11 β -hydroxysteroid dehydrogenase type 1 activity decreases hypertension, insulin resistance, and hypertriglyceridemia in metabolic syndrome.

Schnackenberg CG, Costell MH, Krosky DJ, Cui J, Wu CW, Hong VS, Harpel MR, Willette RN, Yue TL.

Biomed Res Int. 2013;2013:427640. doi: 10.1155/2013/427640. Epub 2013 Mar 18.

10.

[Rapid identification of microorganisms based on Fourier transform near infrared spectroscopy].

Yue TL, Wang J, Yuan YH, Gao ZP.

Guang Pu Xue Yu Guang Pu Fen Xi. 2010 Nov;30(11):2945-9. Chinese.

PMID:
21284159
11.

Optimization of microwave-assisted extraction of polyphenols from apple pomace using response surface methodology and HPLC analysis.

Bai XL, Yue TL, Yuan YH, Zhang HW.

J Sep Sci. 2010 Dec;33(23-24):3751-8. doi: 10.1002/jssc.201000430.

PMID:
21077127
12.

Bis[4-(2-benzoyl-1-oxidoethen-yl)-3-hy-droxy-phenyl benzoato]diethano-l-cobalt(II).

Bai XL, Yue TL, Yuan YH, Zhang HW.

Acta Crystallogr Sect E Struct Rep Online. 2010 Jul 31;66(Pt 8):m1038-9. doi: 10.1107/S1600536810029776.

13.

[Modeling of sugar content based on NIRS during cider-making fermentation].

Peng BZ, Yue TL, Yuan YH, Gao ZP.

Guang Pu Xue Yu Guang Pu Fen Xi. 2009 Mar;29(3):652-5. Chinese.

PMID:
19455792
14.

Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists.

Liu HR, Tao L, Gao E, Qu Y, Lau WB, Lopez BL, Christopher TA, Koch W, Yue TL, Ma XL.

Cardiovasc Res. 2009 Feb 1;81(2):344-52. doi: 10.1093/cvr/cvn308. Epub 2008 Nov 14.

15.

Systemic activation of the transient receptor potential vanilloid subtype 4 channel causes endothelial failure and circulatory collapse: Part 2.

Willette RN, Bao W, Nerurkar S, Yue TL, Doe CP, Stankus G, Turner GH, Ju H, Thomas H, Fishman CE, Sulpizio A, Behm DJ, Hoffman S, Lin Z, Lozinskaya I, Casillas LN, Lin M, Trout RE, Votta BJ, Thorneloe K, Lashinger ES, Figueroa DJ, Marquis R, Xu X.

J Pharmacol Exp Ther. 2008 Aug;326(2):443-52. doi: 10.1124/jpet.107.134551. Epub 2008 May 22. Erratum in: J Pharmacol Exp Ther. 2011 Jul;338(1):408-9.

PMID:
18499744
16.

In vivo activation of peroxisome proliferator-activated receptor-delta protects the heart from ischemia/reperfusion injury in Zucker fatty rats.

Yue TL, Nerurkar SS, Bao W, Jucker BM, Sarov-Blat L, Steplewski K, Ohlstein EH, Willette RN.

J Pharmacol Exp Ther. 2008 May;325(2):466-74. doi: 10.1124/jpet.107.135327. Epub 2008 Feb 20.

PMID:
18287212
17.

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects.

Johns DG, Behm DJ, Walker DJ, Ao Z, Shapland EM, Daniels DA, Riddick M, Dowell S, Staton PC, Green P, Shabon U, Bao W, Aiyar N, Yue TL, Brown AJ, Morrison AD, Douglas SA.

Br J Pharmacol. 2007 Nov;152(5):825-31. Epub 2007 Aug 20.

18.

Effects of p38 MAPK Inhibitor on angiotensin II-dependent hypertension, organ damage, and superoxide anion production.

Bao W, Behm DJ, Nerurkar SS, Ao Z, Bentley R, Mirabile RC, Johns DG, Woods TN, Doe CP, Coatney RW, Ohlstein JF, Douglas SA, Willette RN, Yue TL.

J Cardiovasc Pharmacol. 2007 Jun;49(6):362-8.

PMID:
17577100
19.

P38 MAPK inhibitors suppress biomarkers of hypertension end-organ damage, osteopontin and plasminogen activator inhibitor-1.

Nerurkar SS, Olzinski AR, Frazier KS, Mirabile RC, O'Brien SP, Jing J, Rajagopalan D, Yue TL, Willette RN.

Biomarkers. 2007 Jan-Feb;12(1):87-112.

PMID:
17438656
20.

Lipopolysaccharide (LPS) contamination plays the real role in C-reactive protein-induced IL-6 secretion from human endothelial cells in vitro.

Nerurkar SS, McDevitt PJ, Scott GF, Johanson KO, Willette RN, Yue TL.

Arterioscler Thromb Vasc Biol. 2005 Sep;25(9):e136. No abstract available.

PMID:
16127022
23.

Anti-apoptotic effects of rosiglitazone in hypercholesterolemic rabbits subjected to myocardial ischemia and reperfusion.

Liu HR, Tao L, Gao E, Lopez BL, Christopher TA, Willette RN, Ohlstein EH, Yue TL, Ma XL.

Cardiovasc Res. 2004 Apr 1;62(1):135-44.

PMID:
15023560
24.

Inhibition of Rho-kinase protects the heart against ischemia/reperfusion injury.

Bao W, Hu E, Tao L, Boyce R, Mirabile R, Thudium DT, Ma XL, Willette RN, Yue TL.

Cardiovasc Res. 2004 Feb 15;61(3):548-58.

PMID:
14962485
25.
26.

Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia.

Tao L, Liu HR, Gao E, Teng ZP, Lopez BL, Christopher TA, Ma XL, Batinic-Haberle I, Willette RN, Ohlstein EH, Yue TL.

Circulation. 2003 Dec 2;108(22):2805-11. Epub 2003 Nov 10.

PMID:
14610009
27.

Activation of peroxisome proliferator-activated receptor-alpha protects the heart from ischemia/reperfusion injury.

Yue TL, Bao W, Jucker BM, Gu JL, Romanic AM, Brown PJ, Cui J, Thudium DT, Boyce R, Burns-Kurtis CL, Mirabile RC, Aravindhan K, Ohlstein EH.

Circulation. 2003 Nov 11;108(19):2393-9. Epub 2003 Oct 13.

PMID:
14557369
28.

Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin alphavbeta3) antagonists.

Miller WH, Manley PJ, Cousins RD, Erhard KF, Heerding DA, Kwon C, Ross ST, Samanen JM, Takata DT, Uzinskas IN, Yuan CC, Haltiwanger RC, Gress CJ, Lark MW, Hwang SM, James IE, Rieman DJ, Willette RN, Yue TL, Azzarano LM, Salyers KL, Smith BR, Ward KW, Johanson KO, Huffman WF.

Bioorg Med Chem Lett. 2003 Apr 17;13(8):1483-6.

PMID:
12668017
29.

Idoxifene causes endothelium-dependent, nitric oxide-mediated vasorelaxation in male rats.

Christopher TA, Lopez BL, Stillwagon JC, Gao F, Gao E, Ma XL, Ohlstein EH, Yue TL.

Eur J Pharmacol. 2002 Jun 20;446(1-3):139-43.

PMID:
12098595
30.

Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9.

Romanic AM, Harrison SM, Bao W, Burns-Kurtis CL, Pickering S, Gu J, Grau E, Mao J, Sathe GM, Ohlstein EH, Yue TL.

Cardiovasc Res. 2002 Jun;54(3):549-58.

PMID:
12031700
31.
32.

p38 MAPK inhibition reduces myocardial reperfusion injury via inhibition of endothelial adhesion molecule expression and blockade of PMN accumulation.

Gao F, Yue TL, Shi DW, Christopher TA, Lopez BL, Ohlstein EH, Barone FC, Ma XL.

Cardiovasc Res. 2002 Feb 1;53(2):414-22.

PMID:
11827692
33.

In vivo myocardial protection from ischemia/reperfusion injury by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone.

Yue Tl TL, Chen J, Bao W, Narayanan PK, Bril A, Jiang W, Lysko PG, Gu JL, Boyce R, Zimmerman DM, Hart TK, Buckingham RE, Ohlstein EH.

Circulation. 2001 Nov 20;104(21):2588-94.

PMID:
11714655
34.

Oxidative inactivation of nitric oxide and endothelial dysfunction in stroke-prone spontaneous hypertensive rats.

Ma XL, Gao F, Nelson AH, Lopez BL, Christopher TA, Yue TL, Barone FC.

J Pharmacol Exp Ther. 2001 Sep;298(3):879-85.

PMID:
11504780
35.

Activation of caspase-3/caspase-3-like activity in rat cardiomyocytes by an RGD peptide, but not the GPIIb/IIIa antagonist lotrafiban.

Erhardt JA, Ohlstein EH, Toomey JR, Gabriel MA, Willette RN, Yue TL, Barone FC, Parsons AA.

Thromb Res. 2001 Jul 15;103(2):143-8. No abstract available.

PMID:
11457472
36.

Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury.

Yue TL, Vickery-Clark L, Louden CS, Gu JL, Ma XL, Narayanan PK, Li X, Chen J, Storer B, Willette R, Gossett KA, Ohlstein EH.

Circulation. 2000 Nov 7;102(19 Suppl 3):III281-8.

PMID:
11082402
37.

Nitric oxide stimulatory and endothelial protective effects of idoxifene, a selective estrogen receptor modulator, in the splanchnic artery of the ovariectomized rat.

Ma XL, Gao F, Yao CL, Chen J, Lopez BL, Christopher TA, Disa J, Gu JL, Ohlstein EH, Yue TL.

J Pharmacol Exp Ther. 2000 Nov;295(2):786-92.

PMID:
11046119
38.

Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model.

Gao F, Chen J, Lopez BL, Christopher TA, Gu J, Lysko P, Ruffolo RR Jr, Ohlstein EH, Ma XL, Yue TL.

Eur J Pharmacol. 2000 Oct 6;406(1):109-16.

PMID:
11011041
39.

Extracellular signal-regulated kinase plays an essential role in hypertrophic agonists, endothelin-1 and phenylephrine-induced cardiomyocyte hypertrophy.

Yue TL, Gu JL, Wang C, Reith AD, Lee JC, Mirabile RC, Kreutz R, Wang Y, Maleeff B, Parsons AA, Ohlstein EH.

J Biol Chem. 2000 Dec 1;275(48):37895-901.

40.

A comparison of carvedilol and metoprolol antioxidant activities in vitro.

Lysko PG, Webb CL, Gu JL, Ohlstein EH, Ruffolo RR Jr, Yue TL.

J Cardiovasc Pharmacol. 2000 Aug;36(2):277-81.

PMID:
10942172
41.

Expression of interleukin-1beta, interleukin-1 receptor, and interleukin-1 receptor antagonist mRNA in rat carotid artery after balloon angioplasty.

Wang X, Romanic AM, Yue TL, Feuerstein GZ, Ohlstein EH.

Biochem Biophys Res Commun. 2000 Apr 29;271(1):138-43.

PMID:
10777693
42.

Inhibition of extracellular signal-regulated kinase enhances Ischemia/Reoxygenation-induced apoptosis in cultured cardiac myocytes and exaggerates reperfusion injury in isolated perfused heart.

Yue TL, Wang C, Gu JL, Ma XL, Kumar S, Lee JC, Feuerstein GZ, Thomas H, Maleeff B, Ohlstein EH.

Circ Res. 2000 Mar 31;86(6):692-9.

PMID:
10747006
43.
44.

Apoptosis: a potential target for discovering novel therapies for cardiovascular diseases.

Yue TL, Ohlstein EH, Ruffolo RR Jr.

Curr Opin Chem Biol. 1999 Aug;3(4):474-80. Review.

PMID:
10419841
45.

Inhibition of p38 mitogen-activated protein kinase decreases cardiomyocyte apoptosis and improves cardiac function after myocardial ischemia and reperfusion.

Ma XL, Kumar S, Gao F, Louden CS, Lopez BL, Christopher TA, Wang C, Lee JC, Feuerstein GZ, Yue TL.

Circulation. 1999 Apr 6;99(13):1685-91.

PMID:
10190877
46.

In vitro and in vivo characterization of intrinsic sympathomimetic activity in normal and heart failure rats.

Willette RN, Aiyar N, Yue TL, Mitchell MP, Disa J, Storer BL, Naselsky DP, Stadel JM, Ohlstein EH, Ruffolo RR Jr.

J Pharmacol Exp Ther. 1999 Apr;289(1):48-53.

PMID:
10086986
47.
48.

Discovery of an imidazopyridine-containing 1,4-benzodiazepine nonpeptide vitronectin receptor (alpha v beta 3) antagonist with efficacy in a restenosis model.

Keenan RM, Lago MA, Miller WH, Ali FE, Cousins RD, Hall LB, Hwang SM, Jakas DR, Kwon C, Louden C, Nguyen TT, Ohlstein EH, Rieman DJ, Ross ST, Samanen JM, Smith BR, Stadel J, Takata DT, Vickery L, Yuan CC, Yue TL.

Bioorg Med Chem Lett. 1998 Nov 17;8(22):3171-6.

PMID:
9873697
49.

SB 211475, a metabolite of carvedilol, reduces infarct size after myocardial ischemic and reperfusion injury in rabbits.

Brunvand H, Liu G, Ma XL, Yue TL, Ruffolo RR Jr, Feuerstein GZ.

Eur J Pharmacol. 1998 Sep 4;356(2-3):193-8.

PMID:
9774249
50.

Prolonged expression of interferon-inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in rat.

Wang X, Ellison JA, Siren AL, Lysko PG, Yue TL, Barone FC, Shatzman A, Feuerstein GZ.

J Neurochem. 1998 Sep;71(3):1194-204.

Supplemental Content

Support Center